• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS / RESPIRONICS, INC. PHILIPS RESPRIRONICS DREAM STATION 2; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS / RESPIRONICS, INC. PHILIPS RESPRIRONICS DREAM STATION 2; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Bacterial Infection (1735); Headache (1880); Unspecified Respiratory Problem (4464)
Event Date 10/01/2021
Event Type  Injury  
Event Description
My phillips dreamstation 1 was replaced with a philips dreamstation 2 and i am still have chronic headaches, sinus congestion, and sinus infections.Fda safety report id #:(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHILIPS RESPRIRONICS DREAM STATION 2
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS / RESPIRONICS, INC.
MDR Report Key13603382
MDR Text Key286369604
Report NumberMW5107728
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 02/23/2022
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received02/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ATORVASTATIN ; LISINOPRIL ; METFORMIN ; VITAMIN D3; XARELTO
Patient Outcome(s) Disability;
Patient Age68 YR
Patient SexFemale
Patient Weight95 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-